J3411 HCPCS code: Injection, thiamine hcl, 100 mg
J3411 is the HCPCS Level II code for injection, thiamine hcl, 100 mg. In 2024 Medicare paid an average of $1.65 per service for J3411 across 85,216 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 8 per day on outpatient hospital claims. Medicare volume fell 67% from 2022 to 2024 (255,060 to 85,216 services). In 2024, about 409 clinicians billed Medicare for J3411 for 3,925 beneficiaries; Oklahoma, California, Virginia accounted for 71% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2004-01-01 |
| Last action effective | 2004-01-01 |
Who bills J3411 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 409 |
| Medicare beneficiaries | 3,925 |
| States with claims | 21 |
| Share of services in top 3 states (Oklahoma, California, Virginia) | 71% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J3411, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 255,060 | 7,700 | $2.67 | $2.09 |
| 2023 | 126,538 | 5,269 | $2.48 | $1.95 |
| 2024 | 85,216 | 3,925 | $2.08 | $1.65 |
States with the most J3411 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Oklahoma | 38,210 | $1.65 |
| California | 13,289 | $1.63 |
| Virginia | 8,505 | $1.72 |
| Colorado | 4,942 | $1.61 |
| Florida | 4,463 | $1.68 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 8 | Clinical: Data |
| practitioner claims | 4 | Clinical: Data |
What changed for J3411
- 2004-01-01: J3411 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J3411?
J3411 is the HCPCS Level II code for injection, thiamine hcl, 100 mg. Short descriptor: "Thiamine hcl 100 mg".
How much does Medicare pay for J3411?
In 2024, the average Medicare payment was $1.65 per service (average allowed $2.08).
Does Medicare cover J3411?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J3411 can be billed per day?
8 on outpatient hospital claims; 4 on practitioner claims (NCCI medically unlikely edits).
Related J34 codes
- J3400 — Injection, triflupromazine hcl, up to 20 mg
- J3401 — Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml
- J3402 — Injection, remestemcel-l-rknd, per therapeutic dose
- J3403 — Revakinagene taroretcel-lwey, per implant
- J3404 — Injection, zopapogene imadenovec-drba suspension, per therapeutic dose
- J3405 — Injection, onasemnogene abeparvovec-brve, per treatment
- J3406 — Injection, omidubicel-onlv, per therapeutic dose
- J3410 — Injection, hydroxyzine hcl, up to 25 mg
- J3415 — Injection, pyridoxine hcl, 100 mg
- J3420 — Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
- J3424 — Injection, hydroxocobalamin, intravenous, 25 mg
- J3425 — Injection, hydroxocobalamin, intramuscular, 10 mcg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J3411
- Watch J3411 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J3411
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.